Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What should the investigator document and explain to the sponsor regarding unblinding?

When a trial is blinded, keeping the assignment hidden is important for reducing bias, but if unblinding happens, it must be documented and explained to the sponsor. This is especially true for premature unblinding—unblinding that occurs outside of pre-planned events or emergencies. The investigator should record the exact reason for unblinding, the date and time, which subject’s or which treatment assignment was revealed, who performed or authorized the unblinding, and any immediate impact on patient care or on the study’s conduct. The sponsor needs this information to assess safety implications, potential bias in efficacy assessments, and overall trial integrity, and to determine whether any protocol or safety actions are needed. Even when unblinding is planned, it should be clearly documented and communicated, but the question centers on the need to report and explain premature unblinding to the sponsor.

When a trial is blinded, keeping the assignment hidden is important for reducing bias, but if unblinding happens, it must be documented and explained to the sponsor. This is especially true for premature unblinding—unblinding that occurs outside of pre-planned events or emergencies. The investigator should record the exact reason for unblinding, the date and time, which subject’s or which treatment assignment was revealed, who performed or authorized the unblinding, and any immediate impact on patient care or on the study’s conduct. The sponsor needs this information to assess safety implications, potential bias in efficacy assessments, and overall trial integrity, and to determine whether any protocol or safety actions are needed. Even when unblinding is planned, it should be clearly documented and communicated, but the question centers on the need to report and explain premature unblinding to the sponsor.